The story of Viagra and its creator , copyright, presents a tangled picture for prospective investors. While the revolutionary drug initially produced enormous revenues , its protection has expired , leading to generic versions flooding the arena. This decline in pricing presents a real obstacle for copyright and any company considering a large sta